Ascentage Pharma Group International (AAPG) Interest Expenses (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Interest Expenses for 3 consecutive years, with $7.0 million the latest figure, recorded in Q4 2025.

• Quarterly Interest Expenses rose 2101.24% year-over-year to $7.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.0 million (up 2101.24% YoY) and the FY2025 annual result came in at $7.7 million, down 12.43% from the prior year.
• Interest Expenses advanced to $7.0 million in Q4 2025 per AAPG's latest filing, from $317272.6 in the prior quarter.
• Over the last five years, Interest Expenses for AAPG reached as high as $7.0 million in Q4 2025 and fell as low as $183470.2 in Q4 2023.
• A 3-year average of $2.5 million and a median of $317272.6 in 2024 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2024 — Interest Expenses soared 72.93% — and 2025, when it surged 2101.24%.
• Year by year, Interest Expenses stood at $183470.2 in 2023, then jumped by 72.93% to $317272.6 in 2024, then soared by 2101.24% to $7.0 million in 2025.
• According to Business Quant data, Interest Expenses over the past three periods registered $7.0 million, $317272.6, and $183470.2 for Q4 2025, Q4 2024, and Q4 2023 respectively.